Company intelligence / Profile preview
Guangzhou Green Cross Pharmaceutical
- Ownership
- Private
- Development stage
- Other
Overview
Guangzhou Green Cross Pharmaceutical Co., Ltd. was founded in 1991 and is a leading company in China for amino acid injections and high-end parenteral nutritional preparations. They are also a comprehensive service provider of a wide range of chemical drugs. The company has at least one product (dexamethasone palmitate) in Phase 3 clinical trials for osteoarthritis/knee pain and operates multiple R&D centers and GMP-certified manufacturing bases, focusing on advanced drug delivery technologies.
- Therapeutic areas
- Metabolic DisordersGastroenterologyRheumatologyOther
- Modalities
- Small moleculePeptide drugsLipid microsphere drug delivery technology
- Industry
- Biotech
Drug pipeline
11 assets10 more assets in the full pipeline.
Beyond the preview
Go deeper on Guangzhou Green Cross Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Guangzhou Green Cross Pharmaceutical.